Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches (2020)
- Authors:
- Autor USP: SILVA, CARLOS HENRIQUE TOMICH DE PAULA DA - FCFRP
- Unidade: FCFRP
- DOI: 10.3390/molecules25051245
- Subjects: ADENOSINA; ANTI-INFLAMATÓRIOS; FARMACOCINÉTICA; TOXICOLOGIA; INDÚSTRIA FARMACÊUTICA
- Keywords: Adenosine A2A receptor; Virtual screening; Molecular insight
- Agências de fomento:
- Language: Inglês
- Imprenta:
- Source:
- Este periódico é de acesso aberto
- Este artigo é de acesso aberto
- URL de acesso aberto
- Cor do Acesso Aberto: gold
- Licença: cc-by
-
ABNT
SANTOS, Kelton Luis Belém dos et al. Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches. Molecules, v. 25, n. 5, p. 1-33, 2020Tradução . . Disponível em: https://doi.org/10.3390/molecules25051245. Acesso em: 24 abr. 2024. -
APA
Santos, K. L. B. dos, Cruz, J. N., Silva, L. B., Ramos, R. S., Neto, M. F. A., Lobato, C. C., et al. (2020). Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches. Molecules, 25( 5), 1-33. doi:10.3390/molecules25051245 -
NLM
Santos KLB dos, Cruz JN, Silva LB, Ramos RS, Neto MFA, Lobato CC, Ota SSB, Leite FHA, Borges RS, Silva CHT de P da, Campos JM, Santos CBR dos. Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches [Internet]. Molecules. 2020 ; 25( 5): 1-33.[citado 2024 abr. 24 ] Available from: https://doi.org/10.3390/molecules25051245 -
Vancouver
Santos KLB dos, Cruz JN, Silva LB, Ramos RS, Neto MFA, Lobato CC, Ota SSB, Leite FHA, Borges RS, Silva CHT de P da, Campos JM, Santos CBR dos. Identification of novel chemical entities for Adenosine receptor type 2A using molecular modeling approaches [Internet]. Molecules. 2020 ; 25( 5): 1-33.[citado 2024 abr. 24 ] Available from: https://doi.org/10.3390/molecules25051245 - Química computacional no planejamento de candidatos a quimioterápicos
- Planejamento racional de inibidores de enzimas-alvo aplicado a diferentes doenças: modelagem, síntese, bioquímica e QSAR
- RNA interference in drug discovery
- Homology modelling, virtual screening and molecular dynamics of the MARK3 KA1 domain for cancer drug design
- Sequence and transcriptional study of HNRPK pseudogenes, and expression and molecular modeling analysis of hnRNP K isoforms
- Use of virtual screening, flexible docking, and molecular interaction fields to design novel HMG-CoA reductase inhibitors for the treatment of hypercholesterolemia
- Computer-aided drug design and ADMET predictions for identification and evaluation of novel potential farnesyltransferase
- General aspects of lead finding and optimization in drug discovery
- Molecular dynamics, density functional theory, pharmacophore modeling, molecular interaction fields and ADME/tox investigation of novel bioactive compounds interacting with CDK2 surfaces
- Pharmacophore-based drug design of novel potential tau ligands for Alzheimer's disease treatment
Informações sobre o DOI: 10.3390/molecules25051245 (Fonte: oaDOI API)
Download do texto completo
| Tipo | Nome | Link | |
|---|---|---|---|
 | 002999949.pdf | Direct link |
How to cite
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
